Skip to main content
Equibles
RXRX $3.25 -5.53%
RXRX logo
RXRX · Recursion Pharmaceuticals, Inc.
Track RXRX — free

Use RXRX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.25 -0.19 (-5.53%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.94B
Shares
535.34M
All earnings calls

Earnings call · FY2026 Q2

Recursion Pharmaceuticals, Inc. (RXRX) Q2 2026 Earnings Call

Concluded Aug 5, 2026
Aug 5, 2026 0 turns
Period
FY2026 Q2
Runtime
—
Sources
3 artifacts
Slides 38 8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Revenue $7.67M -60.1% YoY
Diluted EPS -$0.25
Net income -$131.00M

Research materials

Open the source you need; every reader stays inside this workspace.

Presentation 38 slides 8-K earnings release Filed Aug 5, 2026 10-Q report Filed Aug 5, 2026 Company webcastOpen the original investor-relations page

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License And Service$7.30M -61.8% YoY
Grant$367,000 +205.8% YoY
Full-screen source Call document

RXRX transcript alerts

Recursion Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →